Les activités du CHUV
Centre de la prostate
Accueil > Recherche > Publications > Publications 2012

Publications de l'année 2012

Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells.

Tawadros T, Brown MD, Hart CA, Clarke NW.

Br J Cancer. 2012 Nov 6;107(10):1737-44. doi: 10.1038/bjc.2012.457. Epub 2012 Oct 4.


The differential effects of statins on the metastatic behaviour of prostate cancer.

Brown M, Hart C, Tawadros T, Ramani V, Sangar V, Lau M, Clarke N.

Br J Cancer. 2012 May 8;106(10):1689-96. doi: 10.1038/bjc.2012.138. Epub 2012 Apr 24.


Evaluation of the respiratory prostate motion with four-dimensional computed tomography scan acquisitions using three implanted markers.

Udrescu C, Jalade P, de Bari B, Michel-Amadry G, Chapet O.

Radiother Oncol. 2012 May;103(2):266-9. doi: 10.1016/j.radonc.2012.03.016. Epub 2012 Apr 20.


Urology in 2011.

Jichlinski P.

Rev Med Suisse. 2012 Jan 11;8(323):61-3. French.


Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07).

Cathomas R, Rothermundt C, Klingbiel D, Bubendorf L, Jaggi R, Betticher DC, Brauchli P, Cotting D, Droege C, Winterhalder R, Siciliano D, Berthold DR, Pless M, Schiess R, von Moos R, Gillessen S; Swiss Group for Clinical Cancer Research SAKK.

Clin Cancer Res. 2012 Nov 1;18(21):6049-57. doi: 10.1158/1078-0432.CCR-12-2219. Epub 2012 Sep 12.